Microarray-based MALDI-TOF mass spectrometry enables monitoring of monoclonal antibody production in batch and perfusion cell cultures

Journal Article (2016)
Author(s)

Robert F. Steinhoff (ETH Zürich)

Daniel J. Karst (ETH Zürich)

Fabian Steinebach (ETH Zürich)

Marie R.G. Kopp (ETH Zürich)

Gregor W. Schmidt (ETH Zürich)

Alexander Stettler (ETH Zürich)

Jasmin Krismer (ETH Zürich)

Miroslav Soos (University of Chemistry and Technology Prague)

Martin Pabst (ETH Zürich)

undefined More Authors (External organisation)

Affiliation
External organisation
DOI related publication
https://doi.org/10.1016/j.ymeth.2015.12.011
More Info
expand_more
Publication Year
2016
Language
English
Affiliation
External organisation
Volume number
104
Pages (from-to)
33-40
Downloads counter
63

Abstract

Cell culture process monitoring in monoclonal antibody (mAb) production is essential for efficient process development and process optimization. Currently employed online, at line and offline methods for monitoring productivity as well as process reproducibility have their individual strengths and limitations. Here, we describe a matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS)-based on a microarray for mass spectrometry (MAMS) technology to rapidly monitor a broad panel of analytes, including metabolites and proteins directly from the unpurified cell supernatant or from host cell culture lysates. The antibody titer is determined from the intact antibody mass spectra signal intensity relative to an internal protein standard spiked into the supernatant. The method allows a semi-quantitative determination of light and heavy chains. Intracellular mass profiles for metabolites and proteins can be used to track cellular growth and cell productivity.

No files available

Metadata only record. There are no files for this record.